Research progress on the treatment of infertility resulting from a thin endometrium using menstrual blood–derived mesenchymal stem cells: from regenerative potential to challenges in clinical translation

Background A thin endometrium (TE) importantly influences female fertility and the outcomes of assisted reproductive methods. Its pathogenesis involves multiple processes, including basal layer injury, impaired angiogenesis, stromal fibrosis, and reduced regenerative capacity. Menstrual blood–derived mesenchymal stem cells (MenSCs) have attracted increasing attention in endometrial regenerative medicine because of their proliferative and paracrine properties. However, evidence regarding their use in TE remains fragmented, with relatively limited data from TE-specific models and clinical studies. Objective This review summarizes the biological characteristics, potential therapeutic mechanisms, experimental and clinical evidence, and translational challenges of MenSCs for TE treatment. Methods PubMed was searched for studies published through June 2026 on MenSCs in TE and related endometrial disorders. Basic research, animal studies, clinical investigations, and relevant reviews were included. When direct evidence from TE studies was unavailable, mechanistic findings from related models, including intrauterine adhesions (IUAs), Asherman syndrome (AS), endometrial injury, and fibrosis, were evaluated, with explicit differentiation between direct and indirect evidence. Results Current evidence suggests that MenSCs may promote endometrial repair by enhancing cell proliferation and angiogenesis, attenuating fibrosis, modulating the immune microenvironment, and exerting paracrine and extracellular vesicle-mediated effects. Animal studies indicate potential improvements in endometrial thickness and the regeneration of glands and blood vessels, with some studies reporting improved reproductive outcomes. Preliminary clinical studies also suggest therapeutic potential. However, available studies involve small sample sizes, and much of the mechanistic evidence is derived from intrauterine adhesion, AS, or other related models. Direct experimental and high-quality clinical evidence specific to TE remains insufficient. Conclusion MenSCs represent a promising potential strategy for endometrial regeneration, but robust evidence supporting their efficacy and mechanisms in TE is lacking. Future studies should employ TE-relevant disease models, standardized clinical trials, and rigorous protocols for cell preparation, administration, and long-term safety assessment to facilitate clinical translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-13
DOI
https://doi.org/10.3389/fmed.2026.1943776
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Research progress on the treatment of infertility resulting from a thin endometrium using menstrual blood–derived mesenchymal stem cells: from regenerative potential to challenges in clinical translation

Mubai Li, Ni Zheng
1 links
Frontiers in Medicine
Mesenchymal stem cell research
article

Research progress on the treatment of infertility resulting from a thin endometrium using menstrual blood–derived mesenchymal stem cells: from regenerative potential to challenges in clinical translation

Mubai Li, Ni Zheng
article en

Abstract

Background A thin endometrium (TE) importantly influences female fertility and the outcomes of assisted reproductive methods. Its pathogenesis involves multiple processes, including basal layer injury, impaired angiogenesis, stromal fibrosis, and reduced regenerative capacity. Menstrual blood–derived mesenchymal stem cells (MenSCs) have attracted increasing attention in endometrial regenerative medicine because of their proliferative and paracrine properties. However, evidence regarding their use in TE remains fragmented, with relatively limited data from TE-specific models and clinical studies. Objective This review summarizes the biological characteristics, potential therapeutic mechanisms, experimental and clinical evidence, and translational challenges of MenSCs for TE treatment. Methods PubMed was searched for studies published through June 2026 on MenSCs in TE and related endometrial disorders. Basic research, animal studies, clinical investigations, and relevant reviews were included. When direct evidence from TE studies was unavailable, mechanistic findings from related models, including intrauterine adhesions (IUAs), Asherman syndrome (AS), endometrial injury, and fibrosis, were evaluated, with explicit differentiation between direct and indirect evidence. Results Current evidence suggests that MenSCs may promote endometrial repair by enhancing cell proliferation and angiogenesis, attenuating fibrosis, modulating the immune microenvironment, and exerting paracrine and extracellular vesicle-mediated effects. Animal studies indicate potential improvements in endometrial thickness and the regeneration of glands and blood vessels, with some studies reporting improved reproductive outcomes. Preliminary clinical studies also suggest therapeutic potential. However, available studies involve small sample sizes, and much of the mechanistic evidence is derived from intrauterine adhesion, AS, or other related models. Direct experimental and high-quality clinical evidence specific to TE remains insufficient. Conclusion MenSCs represent a promising potential strategy for endometrial regeneration, but robust evidence supporting their efficacy and mechanisms in TE is lacking. Future studies should employ TE-relevant disease models, standardized clinical trials, and rigorous protocols for cell preparation, administration, and long-term safety assessment to facilitate clinical translation.

Frontiers in MedicineVol. 13
First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
Good health and well-being
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon